{"title":"RPA-CRISPR/Cas12a检测ALV-J的广谱检测和减少残留扩增子负载","authors":"Ruiying Han, Ning Xiao, Zhirui Wu, Jiahua Wang, Xiaoli Wang, Xiaochuan Tang","doi":"10.1021/acsinfecdis.6c00419","DOIUrl":null,"url":null,"abstract":"<p>Avian leukosis virus subgroup J (ALV-J)\r\nis a retrovirus\r\nthat poses\r\na serious threat to the poultry industry. It is prone to genetic variation,\r\nleading to the emergence of multiple epidemic strains, which creates\r\nsubstantial challenges for clinical detection. Although the recombinase\r\npolymerase amplification (RPA)-CRISPR/Cas12a rapid detection assay\r\ndemonstrates high sensitivity and specificity, it lacks broad applicability\r\nacross multiple viral strains and is susceptible to amplicon contamination.\r\nIn this study, a mixed crRNA-based CRISPR/Cas12a detection system\r\nwas established. Sequence analysis predicts its potential to cover\r\nmost currently circulating ALV-J variant strains. By optimizing the\r\namount of RPA mix and the buffer conditions, a one-tube RPA-CRISPR/Cas12a\r\nassay was developed, with the lowest tested concentration giving 9/9\r\npositive reactions determined to be 1 × 10<sup>0</sup> copies/μL\r\n(equivalent to 15 copies/reaction in a 15 μL reaction). To simplify\r\nthe sample-handling procedure and reduce detection time, a one-pot\r\nRPA-CRISPR/Cas12a assay was established by adding heparin sodium,\r\nachieving the lowest consistently positive concentration of 1 ×\r\n10<sup>2</sup> copies/μL (1500 copies/reaction). Furthermore,\r\nfor lateral flow assay (LFA) that requires exposure to the environment,\r\nthe concentration of amplicons was reduced by restricting RPA amplification\r\nand employing an enhanced Cas12a protein while maintaining a lowest\r\ntested concentration of 1 × 10<sup>1</sup> copies/μL (150\r\ncopies/reaction). Specificity evaluation revealed no cross-reactivity\r\nwith nontarget avian viruses, yielding a positive signal only for\r\nALV-J. When applied to clinical samples, the one-tube RPA-CRISPR/Cas12a\r\nassay exhibited complete agreement with RT-qPCR in terms of positive\r\ndetection rates. The multiple CRISPR/Cas12a-RPA assays developed in\r\nthis study feature broad strain coverage in principle, high accuracy,\r\nand low contamination risk, providing practical tools for rapid ALV-J\r\ndetection across diverse scenarios.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"12 10","pages":"3408–3418"},"PeriodicalIF":4.5000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"RPA-CRISPR/Cas12a Assay for ALV-J with Broad-Spectrum Detection and Reduced Residual Amplicon Load\",\"authors\":\"Ruiying Han, Ning Xiao, Zhirui Wu, Jiahua Wang, Xiaoli Wang, Xiaochuan Tang\",\"doi\":\"10.1021/acsinfecdis.6c00419\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Avian leukosis virus subgroup J (ALV-J)\\r\\nis a retrovirus\\r\\nthat poses\\r\\na serious threat to the poultry industry. It is prone to genetic variation,\\r\\nleading to the emergence of multiple epidemic strains, which creates\\r\\nsubstantial challenges for clinical detection. Although the recombinase\\r\\npolymerase amplification (RPA)-CRISPR/Cas12a rapid detection assay\\r\\ndemonstrates high sensitivity and specificity, it lacks broad applicability\\r\\nacross multiple viral strains and is susceptible to amplicon contamination.\\r\\nIn this study, a mixed crRNA-based CRISPR/Cas12a detection system\\r\\nwas established. Sequence analysis predicts its potential to cover\\r\\nmost currently circulating ALV-J variant strains. By optimizing the\\r\\namount of RPA mix and the buffer conditions, a one-tube RPA-CRISPR/Cas12a\\r\\nassay was developed, with the lowest tested concentration giving 9/9\\r\\npositive reactions determined to be 1 × 10<sup>0</sup> copies/μL\\r\\n(equivalent to 15 copies/reaction in a 15 μL reaction). To simplify\\r\\nthe sample-handling procedure and reduce detection time, a one-pot\\r\\nRPA-CRISPR/Cas12a assay was established by adding heparin sodium,\\r\\nachieving the lowest consistently positive concentration of 1 ×\\r\\n10<sup>2</sup> copies/μL (1500 copies/reaction). Furthermore,\\r\\nfor lateral flow assay (LFA) that requires exposure to the environment,\\r\\nthe concentration of amplicons was reduced by restricting RPA amplification\\r\\nand employing an enhanced Cas12a protein while maintaining a lowest\\r\\ntested concentration of 1 × 10<sup>1</sup> copies/μL (150\\r\\ncopies/reaction). Specificity evaluation revealed no cross-reactivity\\r\\nwith nontarget avian viruses, yielding a positive signal only for\\r\\nALV-J. When applied to clinical samples, the one-tube RPA-CRISPR/Cas12a\\r\\nassay exhibited complete agreement with RT-qPCR in terms of positive\\r\\ndetection rates. The multiple CRISPR/Cas12a-RPA assays developed in\\r\\nthis study feature broad strain coverage in principle, high accuracy,\\r\\nand low contamination risk, providing practical tools for rapid ALV-J\\r\\ndetection across diverse scenarios.</p>\",\"PeriodicalId\":17,\"journal\":{\"name\":\"ACS Infectious Diseases\",\"volume\":\"12 10\",\"pages\":\"3408–3418\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2026-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00419\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/9/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00419","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/28 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
RPA-CRISPR/Cas12a Assay for ALV-J with Broad-Spectrum Detection and Reduced Residual Amplicon Load
Avian leukosis virus subgroup J (ALV-J)
is a retrovirus
that poses
a serious threat to the poultry industry. It is prone to genetic variation,
leading to the emergence of multiple epidemic strains, which creates
substantial challenges for clinical detection. Although the recombinase
polymerase amplification (RPA)-CRISPR/Cas12a rapid detection assay
demonstrates high sensitivity and specificity, it lacks broad applicability
across multiple viral strains and is susceptible to amplicon contamination.
In this study, a mixed crRNA-based CRISPR/Cas12a detection system
was established. Sequence analysis predicts its potential to cover
most currently circulating ALV-J variant strains. By optimizing the
amount of RPA mix and the buffer conditions, a one-tube RPA-CRISPR/Cas12a
assay was developed, with the lowest tested concentration giving 9/9
positive reactions determined to be 1 × 100 copies/μL
(equivalent to 15 copies/reaction in a 15 μL reaction). To simplify
the sample-handling procedure and reduce detection time, a one-pot
RPA-CRISPR/Cas12a assay was established by adding heparin sodium,
achieving the lowest consistently positive concentration of 1 ×
102 copies/μL (1500 copies/reaction). Furthermore,
for lateral flow assay (LFA) that requires exposure to the environment,
the concentration of amplicons was reduced by restricting RPA amplification
and employing an enhanced Cas12a protein while maintaining a lowest
tested concentration of 1 × 101 copies/μL (150
copies/reaction). Specificity evaluation revealed no cross-reactivity
with nontarget avian viruses, yielding a positive signal only for
ALV-J. When applied to clinical samples, the one-tube RPA-CRISPR/Cas12a
assay exhibited complete agreement with RT-qPCR in terms of positive
detection rates. The multiple CRISPR/Cas12a-RPA assays developed in
this study feature broad strain coverage in principle, high accuracy,
and low contamination risk, providing practical tools for rapid ALV-J
detection across diverse scenarios.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.